Clinical Trial Update: Carboprost (Hemabate) for Fibroid Resection [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial evaluating carboprost (Hemabate) for fibroid uterus resection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Hemabate (carboprost trometamol)

Snippet

Sponsor: Northwestern University | Conditions: Fibroid Uterus, Gynecologic Disease | EARLY_Phase 1 | Status: COMPLETED